Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as GHK Cu Copper Tripeptide Complex for Research VivePeptides Novo Nordisk advances obesity candidate to late stage program after weight loss of less than 12% Cagrilintide (10mg vials) Peptide Partners